At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

At the American Academy of Neurology (AAN) 2025 annual meeting, held in San Diego, California from 5 April to 9 April 2025, acute treatments for migraine were a key topic, with several posters and ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Academy of Neurology (AAN) Annual Meeting, to be held in San Diego, California from April 5 through ...

“We are excited to highlight our clinical and scientific progress at the AAN Annual Meeting, including 3 oral presentations and 10 poster presentations, emphasizing Biohaven’s ...

INTERCEPT-AD Biomarker Results: Early effect of sabirnetug treatment on synaptic biomarkers in Alzheimer's disease (AAN Poster 3-003 in Neighborhood 3) This study was conducted to examine early ...

The poster presentation ... The presentation at the prestigious American Academy of Neurology 2025 Annual Meeting indicates that the research is gaining recognition within the medical community ...

This poster describes the data around a novel breakthrough ... For more information on the AAN Annual Meeting, please refer to www.aan.com. About Vanda Pharmaceuticals Inc. Vanda is a leading ...